Carbapenem or new β-lactam-β-lactamase inhibitors? An Italian survey supported by SITA, SIMIT and SIAARTI to identify the factors affecting empiric antimicrobial therapy choice in real-life clinical practice.
Saved in:
| Title: | Carbapenem or new β-lactam-β-lactamase inhibitors? An Italian survey supported by SITA, SIMIT and SIAARTI to identify the factors affecting empiric antimicrobial therapy choice in real-life clinical practice. |
|---|---|
| Authors: | Colaneri, Marta1,2 (AUTHOR) marta.colaneri@gmail.com, Genovese, Camilla1,3 (AUTHOR), Lombardi, Andrea3,4 (AUTHOR), Holmes, Darcy4 (AUTHOR), Bandera, Alessandra3,4 (AUTHOR), Gori, Andrea1,2 (AUTHOR) |
| Source: | European Journal of Clinical Microbiology & Infectious Diseases. May2024, Vol. 43 Issue 5, p1017-1023. 7p. |
| Database: | Environment Complete |
Be the first to leave a comment!
